Venous thromboembolism risk factor assessment and prophylaxis
- PMID: 20870868
- PMCID: PMC4487984
- DOI: 10.1258/phleb.2010.010018
Venous thromboembolism risk factor assessment and prophylaxis
Abstract
Venous thromboembolism is a common and potentially preventable disease in hospitalized patients. Risk assessment and prophylaxis is also an important quality of care measure. Herein, we discuss the negative impact of VTE on surgical patients, review the risk factors for VTE, the risk assessment tools, available prophylaxis, and then summarize the use of biomarkers for VTE diagnosis.
Figures
References
-
- Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Engl J Med. 2008 - PubMed
-
- Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Circulation. 2009. Heart Disease and Stroke Statistics--2010 Update. A Report From the American Heart Association. - PubMed
-
- Henke P, Froehlich J, Upchurch G, Jr, Wakefield T. The significant negative impact of in-hospital venous thromboembolism after cardiovascular procedures. Ann Vasc Surg. 2007;21(5):545–550. - PubMed
-
- Gangireddy C, Rectenwald JR, Upchurch GR, Wakefield TW, Khuri S, Henderson WG, Henke PK. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007;45(2):335–341. discussion 341-332. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
